熱銷產(chǎn)品：Corning® NK細(xì)胞無血清培養(yǎng)，TAKARA GT-T551 H3無血清培養(yǎng)基

更多腫瘤治療NK細(xì)胞無血清培養(yǎng)基：

X-VIVO 20 medium

AIM-V serum-free medium

RPMI 1640

CellGro SCGM serum free medium等

Corning® NK細(xì)胞活化擴(kuò)增培養(yǎng)套裝

應(yīng)用：NK細(xì)胞活化擴(kuò)增

品牌產(chǎn)地：美國Corning

保存：2°C - 8°C

貨號：88-570-kit

康寧NK細(xì)胞培養(yǎng)套裝包括活化與擴(kuò)增兩個部分。相比同類產(chǎn)品，NK細(xì)胞具有產(chǎn)量高，活性高，殺傷力強(qiáng)的特點(diǎn)。

NK細(xì)胞是重要的免疫細(xì)胞，能識別并清除腫瘤和病毒感染。體外大量培養(yǎng)NK細(xì)胞，滿足免疫治療所需一向比較困難。據(jù)資料，現(xiàn)有的培養(yǎng)方法都是采用擴(kuò)增培養(yǎng)基搭配細(xì)胞因子（IL-2，IL-7，IL-15）的方案，需要研究者自行優(yōu)化后使用。而康寧的培養(yǎng)套裝具備NK細(xì)胞活化擴(kuò)增的全部材料及相應(yīng)的標(biāo)準(zhǔn)操作程序，無需進(jìn)一步的優(yōu)化。

TAKARA GT-T551 H3無血清培養(yǎng)基

適用：淋巴細(xì)胞、DC細(xì)胞、NK細(xì)胞培養(yǎng)

特別應(yīng)用：T細(xì)胞體外培養(yǎng)，與CD3單抗一起活化T細(xì)胞

品牌產(chǎn)地：日本TAKARA（寶日醫(yī)）

保存：2℃- 8℃

產(chǎn)品形態(tài)：透明液體

組份：GT-T551 Culture medium, 1000 mL

GT-T551 H3 是GT-T551的升級版培養(yǎng)基，采用全新的緩沖系統(tǒng)。可用于無血漿培養(yǎng)，CD3+CD56+比例高。如果培養(yǎng)時添加病人自體血漿，效果更為顯著。

華雅再生醫(yī)學(xué)旗艦公司：紅榮微再（上海）生物工程技術(shù)有限公司授權(quán)代理TAKARA CellArtis和Corning免疫細(xì)胞治療產(chǎn)品，主營干細(xì)胞、醫(yī)療、細(xì)胞治療、器官再生四大板塊的產(chǎn)品。歡迎電詢

：  ：1500 1904 520。紅榮微再-客服: 2395557778  經(jīng)銷商專員

Corning® NK細(xì)胞活化擴(kuò)增培養(yǎng)套裝訂購信息

TAKARA GT-T551 H3無血清培養(yǎng)基訂購信息

X-VIVO 20 medium

LONZA X-VIVO 20培養(yǎng)基化學(xué)成分確定，無血清培養(yǎng)造血細(xì)胞。

X-VIVO™ 20開發(fā)優(yōu)化用于從去單核細(xì)胞PBL（外周血淋巴細(xì)胞）中富集LAK細(xì)胞（淋巴因子激活的殺傷細(xì)胞）。X-VIVO™ 20 包含L-谷氨酰胺，慶大霉素和酚紅。

X-VIVO 20 with Gentamicin L-Gln, Phenol Red, 1 L 04-448Q

X-VIVO™ 20 Chemically Defined, Serum-free Hematopoietic Cell Medium

X-VIVO™ 20 was developed and optimized to support the generation of LAK cells from monocyte-depleted PBL at high density. X-VIVO™ 20 contains L-glutamine, gentamicin, and phenol red. Please see Supplemental Information for additional hematopoietic cell applications.

AIM V serum-free medium

AIM V 無血清培養(yǎng)基

*用于免疫研究的商業(yè)化成分確定無血清培養(yǎng)基

FDA 510(k) *明確的商用T細(xì)胞培養(yǎng)基，用于人組織細(xì)胞體外培養(yǎng)。

批間一致，cGMP級生產(chǎn)

培養(yǎng)高性能，不需要血清

Gibco AIM V培養(yǎng)基不需要人血清來優(yōu)化分化淋巴細(xì)胞的生長和活化。

zui小化人血清帶來的病毒免疫原性風(fēng)險

不添加任何細(xì)胞因子和淋巴因子

培養(yǎng)基配方中所有蛋白質(zhì)都具有自然的人類序列

適用免疫細(xì)胞：CD8+ T lymphocytes，Polyclonal T cells，Peripheral blood lymphocytes (PBL)，CD4 cells for HIV patients，Tumor infiltrating lymphocytes (TIL)，Retroviral transduced PBL，CD3 positive NK T cells，Antigen-specific cells (not clonal)，γδ T cells，NK cells等

First commercially available, fully-defined serum-free media for immunological studies

The only FDA 510(k) cleared commercial T-cell medium for human ex vivo tissue and cell culture processing applications

Lot-to-lot consistency and produced under cGMP

Superior performance, no serum required

Gibco AIM V Medium does not require human serum for optimal growth and activation of differentiated lymphoid cells.

Minimizes risk of viral immunogenicity associated with human serum

Contains no added cytokines and lymphokines

All proteins in the formulation have the natural human sequence

RPMI 1640 medium RPMI 1640 培養(yǎng)基

RPMI 1640 培養(yǎng)基本來開發(fā)用于人白血病細(xì)胞培養(yǎng)。之后發(fā)現(xiàn)RPMI 1640適用很多種哺乳動物細(xì)胞培養(yǎng)，包括HeLa, Jurkat, MCF-7, PC12, PBMC, astrocytes, and carcinomas。文獻(xiàn)有用于CAR T細(xì)胞和NK細(xì)胞等培養(yǎng)。

RPMI 1640 Medium was originally developed to culture human leukemic cells in suspension and as a monolayer. Roswell Park Memorial Institute (RPMI) 1640 Medium has since been found suitable for a variety of mammalian cells, including HeLa, Jurkat, MCF-7, PC12, PBMC, astrocytes, and carcinomas. We offer a variety of RPMI 1640 Medium modifications for a range of cell culture applications. Find the right formulation using the media selector tool.

CellGro SCGM serum free medium

CellGenix® GMP級 SCGM 無血清培養(yǎng)基 干細(xì)胞生長培養(yǎng)基

CellGenix GMP SCGM培養(yǎng)基無血清、無異源物，優(yōu)化用于分離少量人造血干細(xì)胞和祖細(xì)胞（HSCs/CD34+ cells）的擴(kuò)增。用于人NK細(xì)胞和人CIK細(xì)胞培養(yǎng)擴(kuò)增也有。

適用細(xì)胞：造血干細(xì)胞 CIK細(xì)胞 NK細(xì)胞

CellGenix® GMP SCGM 

Stem Cell Growth Medium

CellGenix GMP SCGM is an optimized, xeno-free medium used for the serum-free expansion of low numbers of isolated human hematopoietic stem and progenitor cells (HSCs/CD34+ cells). In addition, our SCGM is proved to be highly efficient for the expansion and c*tion of human natural killer cells (NK cells) and human cytokine induced killer cells (CIK cells).

CELL TYPE

Hematopoietic stem cells (HSC)

Cytokine induced killer cells (CIK cells)

Natural killer cells (NK cells)

日本細(xì)胞研究所ALys medium

適用于人/小鼠淋巴細(xì)胞無血清培養(yǎng)的培養(yǎng)基。

滲透壓：280-300mOsm / kg H 2 O.

過濾器已經(jīng)過消毒。

內(nèi)毒素測試。

*用ALyS培養(yǎng)液進(jìn)行外周血淋巴細(xì)胞的原代培養(yǎng)（活化培養(yǎng)）時，

建議加入少量血清或血漿（1-5％）。自我復(fù)制

開始后，加入血清是不必要的。

ALys 505N medium

可以無血清培養(yǎng)

沒有動物源性成分

所有蛋白質(zhì)

適用人淋巴細(xì)胞無血清培養(yǎng)

ALyS505N-0

ALyS505N-175

ALyS505N-7

ALyS505N-10

Glycostem basal growth medium

Glycostem Basal Growth Medium (GBGM)

Serum free cell culture medium for expansion and differentiation of hematopoietic cells.

Glycostem Basal Growth Medium (GBGM) is a serum free, chemically defined cell culture medium. Specific modifications enable preferred expansion of bone marrow or cord blood stem and progenitor cells.

GBGM is only available for third parties under a MTA licensing agreement.

IMSF100

IMSF 100; Immunotech, London, UK

RHAMα medium

參考文獻(xiàn)

2017年NK細(xì)胞綜述：來源，腫瘤治療方法和潛力

Natural killer cells as a promising tool to tackle cancer—A review of sources, methodologies, and potentials.Senthilkumar Preethy, et al.Pages 220-232 | Received 26 Apr 2016, Accepted 16 Jan 2017, Published online: 04 May 2017

LONZA X-VIVO 20培養(yǎng)基

AIM V 無血清培養(yǎng)基

RPMI 1640 培養(yǎng)基

CellGenix® GMP級 SCGM 無血清培養(yǎng)基 干細(xì)胞生長培養(yǎng)基

華雅再生醫(yī)學(xué)旗艦公司：紅榮微再（上海）生物工程技術(shù)有限公司授權(quán)代理TAKARA CellArtis和Corning等產(chǎn)品。LONZA 、Gibco（Thermo）和CellGenix NK細(xì)胞無血清培養(yǎng)基歡迎電詢。

：  ：1500 1904 520。紅榮微再-客服: 2395557778  經(jīng)銷商專員